Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Times Interest Earned (2022 - 2023)

Century Therapeutics (IPSC) has disclosed Times Interest Earned for 2 consecutive years, with -$257.92 as the latest value for Q2 2023.

  • On a quarterly basis, Times Interest Earned fell 234.01% to -$257.92 in Q2 2023 year-over-year; TTM through Mar 2024 was -$1071.9, a 1376.7% decrease, with the full-year FY2023 number at -$271.38, down 189.97% from a year prior.
  • Times Interest Earned was -$257.92 for Q2 2023 at Century Therapeutics, down from -$92.19 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$51.8 in Q4 2022 to a low of -$257.92 in Q2 2023.